Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
European laboratories move forward towards stronger epidemic readiness for infectious disease threats.
The latest EULabCap data on assessing the public health laboratory capacities among 30 EU and EEA countries in 2016 reveal continuous improvement in reducing inequalities, with ten more countries reaching fair to high capability levels over the 4 years of monitoring.
ECDC ENLabCap consultation meeting with EU enlargement countries
Overall aim of this regional ENLabCap consultation workshop is to discuss the adjustments proposed to the current EULabCap tool and agree on those needed to adapt it for the EU enlargement countries.
Strong engagement of national public health laboratories to respond to communicable disease outbreaks and improve monitoring of antimicrobial resistance in the European Union.
The EU Laboratory Capability (EULabCap) report published today,
on the results of the 2015 survey, concludes that the EU/EEA as a whole has a strong and improving public health microbiology system, with an average EULabCap score of 7.5 on a scale of 10, up from 6.9 in 2013 and 7.3 in 2014.
First indications of improved capability and capacity of public health microbiology laboratories in the European Union
The results of the EU Laboratory Capability Monitoring System (EULabCap) survey on 2014 data confirms that the EU/EEA as a whole can rely on a strong public health microbiology system and substantial capacity to fulfil surveillance and response requirements.
Are public health microbiology laboratories in the European Union prepared for tracking infectious diseases? The first EULabCap report published
The EU Laboratory Capability (EULabCap) report on the 2013 survey concludes that, in general, the public health microbiology laboratories in the EU/EEA are well prepared for diagnosing and characterising infectious disease agents that threaten public health.